Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sorin Group, a developer of medical technologies for the treatment of cardiovascular diseases, and Sphere Medical, a developer of monitoring products for critical care, have signed an agreement to apply Sphere Medical's proprietary microsensor technology in the field of cardiopulmonary bypass.
Subscribe to our email newsletter
Sorin Group and Sphere Medical have undertaken a feasibility study which included an evaluation of Sphere Medical’s microsensor technology in animal and human blood. Following the successful conclusion of that study, Sorin Group has exercised its option to move to a full development and supply agreement.
Under the agreement, Sorin Group and Sphere Medical will jointly undertake a product development in the cardiopulmonary bypass field. The resulting product will be supplied by Sphere Medical and marketed exclusively on a worldwide basis by Sorin Group. In particular, the microsensor technology will be embedded in Sorin Group’s new family of in-line blood monitors and will contribute to improving clinical outcome for patients undergoing cardiac surgery operations.
In addition to the development and supply agreement, Sorin Group will be making an investment in Sphere Medical equity.
Michel Darnaud, president of cardiopulmonary business unit and intercontinental at Sorin Group, said: “We are committed to continuing to deliver product and service excellence to support our worldwide leading position and drive market development through technological innovation. The agreement with Sphere perfectly fits within these goals.”